Mpox Cases Among Cisgender Women and Pregnant Persons — United States, May 11–November 7, 2022
by from Morbidity and Mortality Weekly Report (MMWR) on (#67H09)
This report describes cases of mpox among cisgender women and the use of tecovirimat with no reported adverse reaction to treat four pregnant people with mpox.